Results Snapshot
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Mar 2026 is 14.51% vs -1.81% in Dec 2025
Consolidate Net Profit
QoQ Growth in quarter ended Mar 2026 is 186.96% vs -217.95% in Dec 2025
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Mar 2026 is -34.76% vs -37.16% in Dec 2025
Interest
QoQ Growth in quarter ended Mar 2026 is -100.00% vs 0.00% in Dec 2025
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Mar 2026 has improved from Dec 2025
Compare Quarterly Results Of Qianjiang Yongan Pharmaceutical Co., Ltd. With
Quarterly - Net Sales
QoQ Growth in quarter ended Mar 2026 is 14.51% vs -1.81% in Dec 2025
YoY Growth in quarter ended Mar 2026 is 40.25% vs -14.45% in Mar 2025
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Mar 2026 is 186.96% vs -217.95% in Dec 2025
YoY Growth in quarter ended Mar 2026 is 219.40% vs -123.51% in Mar 2025
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Mar 2026 is -34.76% vs -37.16% in Dec 2025
YoY Growth in quarter ended Mar 2026 is -32.70% vs -63.28% in Mar 2025
Quarterly - Interest
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Mar 2026 has improved from Dec 2025
YoY Growth in quarter ended Mar 2026 has improved from Mar 2025






